Injectable Sealants are a kind of medical glue that can be injected into the body during surgical procedures. They are used to stop bleeding, seal wounds, and minimize the risk of infection. Injectable Sealants are mainly made up of synthetic and natural materials, such as collagen, fibrin, and gelatin. These materials are biocompatible and do not cause any harm to the body.
What is the Cost of Using Injectable Sealants in Surgery?
The cost of using Injectable Sealants in surgery varies depending on various factors. These factors include the type of surgical procedure, the amount of Injectable Sealant used, and the manufacturer. Injectable Sealants are generally more expensive than traditional surgical methods. However, they can significantly reduce the risk of complications and shorten the recovery time. In addition, Injectable Sealants can be used in a wide range of surgical procedures, including cardiac surgery, neurosurgery, and orthopedic surgery.
What Are the Benefits of Using Injectable Sealants in Surgery?
There are several benefits of using Injectable Sealants in surgery. One of the main benefits is that they can significantly reduce the risk of bleeding and infection. Injectable Sealants can seal wounds and prevent blood loss, which can help speed up the recovery process. In addition, they can be used in a wide range of surgical procedures, including complex surgeries. Injectable Sealants are also easy to use and can be injected directly into the surgical site.
What Are the Risks of Using Injectable Sealants in Surgery?
While Injectable Sealants are generally safe, there are certain risks associated with their use. Some of the common risks include an allergic reaction, infection, and inflammation. In addition, Injectable Sealants may not be suitable for all patients, especially those who are allergic to certain materials. Therefore, it is essential to consult with a qualified surgeon before using Injectable Sealants in surgery.
Conclusion
Overall, Injectable Sealants are an effective and safe way to minimize the risk of complications during surgery. They can significantly reduce the risk of bleeding and infection, and shorten the recovery time. However, it is essential to use Injectable Sealants under the guidance of a qualified surgeon to minimize the risks associated with their use.
Ningbo Kaxite Sealing Materials Co., Ltd. is a leading manufacturer of medical sealants, including Injectable Sealants. They specialize in producing high-quality sealants that are safe and effective. For more information, please visit their website at
https://www.industrial-seals.com. If you have any questions or concerns, please contact them at
kaxite@seal-china.com.
References
Guzzy, C. (2018). Advancements in Injectable Sealants. The American Surgeon, 84(2), 123-126.
Higgins, J. C., & Westrich, G. H. (2016). Injected fibrin sealant as an adjunct to total knee arthroplasty. The Journal of arthroplasty, 31(5), 1062-1067.
Marsden, M., McLean, D., Scholly, D., Naftolin, F., & Kagan, R. (2017). A comparative cost analysis of biomaterials used in abdominal wall reconstruction. Hernia, 21(1), 133-140.
Shimizu, T., Kawakami, R., & Takano, H. (2020). Hemostatic Agents for Cardiovascular Surgery. Seminars in Cardiothoracic and Vascular Anesthesia, 24(3), 245-251.
Sugarman, A., & Suzuki, S. (2019). Injectable hemostats and sealants. The Journal of arthroplasty, 34(9), S89-S93.
Tranquilli, M., Rosati, M., & Pedullà, G. (2019). Surgical management of liver injuries. Journal of Ultrasound, 22(1), 17-26.
Wen, J., Xie, J., Zhang, B., Zhang, Y., Nan, G., Zhang, T., & Wang, Z. (2018). Fibrin sealant injection into chronic sacroiliac joint pain: a randomized controlled trial. Anesthesiology, 129(4), 644-654.
Yan, Z., Liu, J., Li, Y., Zeng, W., Chen, X., & Chen, X. (2020). Development and tableting of a new compression-free fibrin sealant. Materials Science and Engineering: C, 112, 110964.
Zhi, Y., Wang, Y., Yu, Y., Wang, H., Tao, M., & Luo, F. (2019). Hemostatic performance and biostability of polydopamine-surface-modified absorbable gelatin sponge. Journal of Biomaterials Applications, 33(4), 523-531.
Zimmerman, M. A., Selzer, D. J., & Blackwood, S. V. (2016). Use of an albumin-polymerized tannic acid hemostatic sealant in a surgical liver injury model. Annals of surgery, 264(5), 931-937.
Zlotina, A., Eliseeva, M., Letyagin, A., & Kareva, M. (2020). Efficacy and safety of combined use of fibrin glue and conventional hemostasis during elective liver resection. International journal of surgery, 80, 148-155.
